PAVmed Inc.
corporate_fare Company Profile
PAVmed Inc. (NASDAQ:PAVM) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for PAVM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-22, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 16 rated 8 or above. Recent SEC coverage for PAVM spans 8-K, 424B5, 10-Q, DEF 14A.
Recent high-impact activity:
- PAVmed's Lucid Diagnostics Raises $15.0M in Series C Preferred at $1,000/Share
- PAVmed Launches $9.4M ATM Facility with A.G.P. After Exhausting Prior Program
- PAVmed Q2: Veris Accelerates OSU Rollout, Lucid Lands First EsoGuard Coverage Policy
- PAVmed Q2 10-Q: Going Concern Warning, Covenant Amendment, and ATM Exhaustion
- Shareholders Approve Significant Increase in Employee Stock Purchase Plan Shares
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 12,717 shares in PAVM as of the October 15, 2026 settlement, a 0.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 30, 2026, 30.1% of PAVM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for PAVM, detected from its recent SEC filings · based on capital-structure filings through 2026-09-09.
New $9.4M ATM Facility · Dilution Impact
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →